The long-term goal of this research is to understand the roles of of this research is to understand the roles of neuroendocrine homeostasis. CRF is the major integrator of these processes. Deviation of major integrator of these processes. Deviation of its regulation is its biological activity by binding two classes of proteins: CRF receptor activity by binding two classes of proteins: CRF receptor and CRF binding modulator. The objective of this proposal is to clarify the role of each objective of this proposal is to clarify the role of each CRF component mutations in each component of the CRF system. This involves: in each component of the CRF system. This involves: 1. Cloning of cDNAs encoding mouse CRF, CRF receptor A (CRF-RA), and CRF- 1. Cloning of cDNAs encoding mouse CRF, CRF receptor A (CRF-RA), and CRF- genomic clones containing these genes for targeted disruption of the CRF-RA of genomic clones containing these genes for targeted disruption of the studied. will be studied. 2. Investigation of effects of targeted disruption of CRF-RA and CRF-BP on 2. Investigation of effects of targeted disruption of CRF-RA and CRF-BP and stressful conditions including neuroendocrine, immune, and reproductive basal and stressful conditions including neuroendocrine immune and developing a strategy to generate mice with the components of CRF system developing a strategy to generate mice with the components of CRF system in the CRF system by intercrossing mice carrying mutations in different in the CRF system by intercrossing mice carrying mutations in different components of CRF system.

Project Start
1997-09-12
Project End
1998-05-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
18
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
005436803
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Spierling, Samantha R; Mattock, Maegan; Zorrilla, Eric P (2017) Modeling hypohedonia following repeated social defeat: Individual vulnerability and dopaminergic involvement. Physiol Behav 177:99-106
Erchegyi, Judit; Wang, Lixin; Gulyas, Jozsef et al. (2016) Characterization of Multisubstituted Corticotropin Releasing Factor (CRF) Peptide Antagonists (Astressins). J Med Chem 59:854-66
Pilbrow, Anna P; Lewis, Kathy A; Perrin, Marilyn H et al. (2016) Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative Splicing. Endocrinology 157:4865-4874
Zhang, Cheng; Kuo, Ching-Chang; Moghadam, Setareh H et al. (2016) Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease. Alzheimers Dement 12:527-37
Zhang, Cheng; Kuo, Ching-Chang; Moghadam, Setareh H et al. (2015) Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model. J Alzheimers Dis 45:639-50
van der Meulen, Talitha; Huising, Mark O (2015) Role of transcription factors in the transdifferentiation of pancreatic islet cells. J Mol Endocrinol 54:R103-17
Radley, Jason J; Sawchenko, Paul E (2015) Evidence for involvement of a limbic paraventricular hypothalamic inhibitory network in hypothalamic-pituitary-adrenal axis adaptations to repeated stress. J Comp Neurol 523:2769-87
van der Meulen, Talitha; Donaldson, Cynthia J; Cáceres, Elena et al. (2015) Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion. Nat Med 21:769-76
Mulak, Agata; Larauche, Muriel; Biraud, Mandy et al. (2015) Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice. Peptides 63:71-80
Cui, Changhai; Noronha, Antonio; Warren, Kenneth R et al. (2015) Brain pathways to recovery from alcohol dependence. Alcohol 49:435-52

Showing the most recent 10 out of 382 publications